ID

33247

Description

Study ID: 107434 Clinical Study ID: NAP107434 Study Title: A randomised, double-blind, double-dummy, placebo controlled, three-way cross-over study to investigate the effect of single oral doses of 100 mg GW273225 (4030W92) and 325 mg LAMICTAL on resting motor threshold in healthy subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Study Link: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GW273225 Trade Name: lamictal Study Indication: Bipolar Disorder This form contains the eligibility criteria of the study. It should be checked at the screening visit. For Inclusion Criteria: A subject will be eligible for inclusion in this study only if all of the following criteria’s apply The following must all be answered ‘Yes’ for the subject to be eligible to take part in the study For Exclusion Criteria: A subject will not be eligible for inclusion in this study only if any of the following criteria’s apply The following must all be answered ‘No’ for the subject to be eligible to take part in the study Screening Visit: 28 days prior to first dosing. Treatment Period: The day before dosing, until 48h after dosing. Follow-Up: 14-21 days after last dose

Mots-clés

Versions (3)
  1. 03/12/2018 03/12/2018 -
  2. 14/12/2018 14/12/2018 -
  3. 19/12/2018 19/12/2018 - Sarah Riepenhausen
Détendeur de droits

GlaxoSmithKline

Téléchargé le

3 décembre 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Effect of Lamictal on Resting Motor Threshold

Anglais

Eligibility Criteria

1 Formulaires  
  1. StudyEvent: ODM
    1. Eligibility Criteria
Administrative Data
Description

Administrative Data

Alias
UMLS CUI-1
C1320722
Subject Screening number
Description

Subject Screening No.

Type de données

integer

Alias
UMLS CUI [1,1]
C0220908
UMLS CUI [1,2]
C0600091
Subject no.
Description

Subject Number

Type de données

integer

Alias
UMLS CUI [1]
C2348585
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
Right-handed healthy male subjects aged between 18 and 55 years, inclusive.
Description

Handedness, Gender, Age

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
UMLS CUI [3]
C0023114
Body weight >50 kg and Body Mass Index (BMI) within the range 19–29.9 kg/m2 inclusive.
Description

Body weight, BMI

Type de données

boolean

Alias
UMLS CUI [1]
C1305855
UMLS CUI [2]
C0005910
No abnormality on relevant clinical examination.
Description

A subject with a clinical abnormality may be included only if the Investigator after discussion with the GSK nominated Medical Monitor considers that the abnormality will not introduce additional risk factors and will not interfere with the study procedures.

Type de données

boolean

Alias
UMLS CUI [1]
C0031809
No abnormality on relevant clinical chemistry or haematology examination at the pre-study medical examination.
Description

Subjects with laboratory parameters outside the reference range for this age group will only be included if the Investigator after discussion with the GSK nominated Medical Monitor considers considers that such findings will not introduce additional risk factors.

Type de données

boolean

Alias
UMLS CUI [1]
C0008000
UMLS CUI [2]
C0018941
A 12-lead ECG at the pre-study medical examination, which is normal.
Description

Subjects with ECG changes may be acceptable for inclusion in the study if the Investigator after discussion with the GSK nominated Medical Monitor considers considers that such findings will not introduce additional risk factors.

Type de données

boolean

Alias
UMLS CUI [1]
C0430456
Signed and dated written informed consent prior to admission to the study
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
The subject is able to understand and comply with protocol requirements, instructions and protocol-stated restrictions.
Description

Protocol Compliance

Type de données

boolean

Alias
UMLS CUI [1]
C0525058
Normal EEG with photo stimulation
Description

EEG with Photo Stimulation

Type de données

boolean

Alias
UMLS CUI [1]
C0430786
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI-1
C0680251
A positive pre-study Hepatitis B suface antigen, Hepatitis C antibody, and Human Immunodeficiency virus (HIV) antibody result at screening examination.
Description

Pre-study HepB, HepC and HIV Antibody Test

Type de données

boolean

Alias
UMLS CUI [1]
C0201487
UMLS CUI [2]
C0201478
UMLS CUI [3]
C2229753
A positive pre-study urine drug test at screening or prior to each treatment period
Description

Urine Drug Test

Type de données

boolean

Alias
UMLS CUI [1]
C0202274
A positive alcohol urine drug test at screening or prior to each treatment period.
Description

Alcohol Urine Drug Test

Type de données

boolean

Alias
UMLS CUI [1,1]
C0202304
UMLS CUI [1,2]
C0042036
An unwillingness of the male subject to use a condom/spermicide in addition to having their female partner use another form of contraception such as an IUD, diaphragm with spermicide, oral contraceptives, injectable progesterone, subdermal implants or a tubal ligation if the woman could become pregnant from the time of the first dose of study medication until 30 days following administration of the last dose of study medication.
Description

Unwillingness of Male Subject to Use Condom plus Femal Partner Unwilling to Use Another Form of Contraception, e.g. IUD, Diaphragm with Spermicide, Oral Contraceptives, Injectable Progesterone, Subdermal Implants or Tubal Ligation

Type de données

boolean

Alias
UMLS CUI [1,1]
C1706180
UMLS CUI [1,2]
C0600109
UMLS CUI [1,3]
C3873750
UMLS CUI [1,4]
C1524063
UMLS CUI [2,1]
C1705497
UMLS CUI [2,2]
C0700589
UMLS CUI [2,3]
C0600109
UMLS CUI [3]
C0021900
UMLS CUI [4]
C0042241
UMLS CUI [5]
C0009905
UMLS CUI [6]
C0544374
UMLS CUI [7]
C0375850
UMLS CUI [8]
C0520483
History or evidence of drug or alcohol abuse within six months of study start.
Description

History of Recent Drug or Alcohol Abuse

Type de données

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0332185
UMLS CUI [1,3]
C0085762
UMLS CUI [2,1]
C0262926
UMLS CUI [2,2]
C0332185
UMLS CUI [2,3]
C0038586
Weekly alcohol intake of more than 21 units or an average daily intake of greater than three units.
Description

One unit is equivalent to half pint of beer (220 mL) or one (25 mL) measure of spirits or one glass (125 mL) of wine.

Type de données

boolean

Alias
UMLS CUI [1,1]
C0001948
UMLS CUI [1,2]
C0332174
Positive pre-study drugs of abuse or alcohol urine test
Description

Drug and Alcohol Urine Test

Type de données

boolean

Alias
UMLS CUI [1,1]
C0202274
UMLS CUI [1,2]
C0868676
UMLS CUI [2,1]
C0202304
UMLS CUI [2,2]
C0042036
Has received prescribed or non-prescribed medication (including vitamins, herbal remedies and antacids) within 7 days prior to the dosing day, which in the opinion of the Principal/Co-Investigator, may interfere with the study procedures or compromise safety. Paracetamol for mild analgesia will be permitted
Description

Recent Medication of Prescribed or Non-Prescribed Medication Excluding Paracetamol

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332185
UMLS CUI [1,2]
C3166216
UMLS CUI [2,1]
C0332185
UMLS CUI [2,2]
C4081824
UMLS CUI [3]
C0042890
UMLS CUI [4]
C1360419
UMLS CUI [5]
C0003138
UMLS CUI [6,1]
C0000970
UMLS CUI [6,2]
C2828389
Participation in a trial with and investigational drug within 30 days or 5 half lives (whichever is longer) prior to dosing
Description

Trial Participation with Investigational Drug

Type de données

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0013230
Donation of blood in excess of 500 mL within 3 months prior to the first dose of study medication
Description

Recent Blood Donation

Type de données

boolean

Alias
UMLS CUI [1,1]
C0005794
UMLS CUI [1,2]
C0332185
History of hypersensitivity to lamotrigine
Description

History of Hypersensitivity to Lamotrigine

Type de données

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0020517
UMLS CUI [1,3]
C0064636
History of clinically relevant skin rashes and allergies that, in the opinion of the investigator, might interfere with the conduct of the study.
Description

History of Skin Rashes and Allergies

Type de données

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0015230
UMLS CUI [2,1]
C0262926
UMLS CUI [2,2]
C0020517
Any subject where the potential CNS side effects of GW273225 and lamotrigine could affect their professional occupation, e.g. operating machinery, driving.
Description

Side Effect Affecting Professional Occupation, Operating Machinery, Driving

Type de données

boolean

Alias
UMLS CUI [1,1]
C0879626
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C2698884
UMLS CUI [2]
C2698884
UMLS CUI [3]
C0004379
Subject has current or past history of seizure disorder or brain injury (traumatic or disease-related), or any condition which, in the opinion of the investigator, predisposes to seizure; subject treated with other medications or treatment regimens that lower seizure threshold; subject undergoing abrupt discontinuation of alcohol or sedatives (including benzodiazepines).
Description

History of Seizure Disorder or Brain Injury, any Condition with Predisposition to Seizure, Treatment with Medications lowering Seizure Threshold or Undergoing Abrupt Discontinuation of Alcohol or Sedatives

Type de données

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0036572
UMLS CUI [2,1]
C0262926
UMLS CUI [2,2]
C0876926
UMLS CUI [3,1]
C0220898
UMLS CUI [3,2]
C0036572
UMLS CUI [4,1]
C0234976
UMLS CUI [4,2]
C0013227
UMLS CUI [5,1]
C0457454
UMLS CUI [5,2]
C0001948
UMLS CUI [6,1]
C0457454
UMLS CUI [6,2]
C0036557
Poorly-controlled migraine headaches
Description

Migraine Headaches Uncontrolled

Type de données

boolean

Alias
UMLS CUI [1,1]
C0149931
UMLS CUI [1,2]
C0205318
Implanted metal devices including pacemakers
Description

Implanted metal Devices, Pacemakers

Type de données

boolean

Alias
UMLS CUI [1,1]
C0025080
UMLS CUI [1,2]
C0021102
UMLS CUI [2]
C0030163
Previous brain neurosurgery
Description

Previous Brain Surgery

Type de données

boolean

Alias
UMLS CUI [1,1]
C0524850
UMLS CUI [1,2]
C0205156
History of neurological disorders and stroke
Description

History of Neurological Disorders and Stroke

Type de données

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0027765
UMLS CUI [2,1]
C0262926
UMLS CUI [2,2]
C0038454
Eligibility Review Following Screening
Description

Eligibility Review Following Screening

Alias
UMLS CUI-1
C0013893
Does the subject satisfy the Inclusion/Exclusion criteria of this study protocol?
Description

If the answer is No, please give the reason below.

Type de données

boolean

Alias
UMLS CUI [1,1]
C0242428
UMLS CUI [1,2]
C1512693
UMLS CUI [2,1]
C0242428
UMLS CUI [2,2]
C0680251
Does the subject satisfy the Inclusion/Exclusion criteria of this study protocol?
Description

If the answer is No, please give the reason below.

Type de données

text

Alias
UMLS CUI [1,1]
C0242428
UMLS CUI [1,2]
C1512693
UMLS CUI [2,1]
C0242428
UMLS CUI [2,2]
C0680251
UMLS CUI [3]
C0947611
Physician's Initials
Description

Physician's Initials

Type de données

text

Alias
UMLS CUI [1,1]
C1997894
UMLS CUI [1,2]
C2986440
Date
Description

Date

Type de données

date

Alias
UMLS CUI [1]
C0011008
Retour au début de la page

Similar models

Eligibility Criteria

1 Formulaires
  1. StudyEvent: ODM
    1. Eligibility Criteria
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Subject Screening No.
Item
Subject Screening number
integer
C0220908 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Subject Number
Item
Subject no.
integer
C2348585 (UMLS CUI [1])
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
Handedness, Gender, Age
Item
Right-handed healthy male subjects aged between 18 and 55 years, inclusive.
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0023114 (UMLS CUI [3])
Body weight, BMI
Item
Body weight >50 kg and Body Mass Index (BMI) within the range 19–29.9 kg/m2 inclusive.
boolean
C1305855 (UMLS CUI [1])
C0005910 (UMLS CUI [2])
Clinical Examination
Item
No abnormality on relevant clinical examination.
boolean
C0031809 (UMLS CUI [1])
Clinical Chemistry, Haematology Examination
Item
No abnormality on relevant clinical chemistry or haematology examination at the pre-study medical examination.
boolean
C0008000 (UMLS CUI [1])
C0018941 (UMLS CUI [2])
12-lead ECG
Item
A 12-lead ECG at the pre-study medical examination, which is normal.
boolean
C0430456 (UMLS CUI [1])
Informed Consent
Item
Signed and dated written informed consent prior to admission to the study
boolean
C0021430 (UMLS CUI [1])
Protocol Compliance
Item
The subject is able to understand and comply with protocol requirements, instructions and protocol-stated restrictions.
boolean
C0525058 (UMLS CUI [1])
EEG with Photo Stimulation
Item
Normal EEG with photo stimulation
boolean
C0430786 (UMLS CUI [1])
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
Pre-study HepB, HepC and HIV Antibody Test
Item
A positive pre-study Hepatitis B suface antigen, Hepatitis C antibody, and Human Immunodeficiency virus (HIV) antibody result at screening examination.
boolean
C0201487 (UMLS CUI [1])
C0201478 (UMLS CUI [2])
C2229753 (UMLS CUI [3])
Urine Drug Test
Item
A positive pre-study urine drug test at screening or prior to each treatment period
boolean
C0202274 (UMLS CUI [1])
Alcohol Urine Drug Test
Item
A positive alcohol urine drug test at screening or prior to each treatment period.
boolean
C0202304 (UMLS CUI [1,1])
C0042036 (UMLS CUI [1,2])
Unwillingness of Male Subject to Use Condom plus Femal Partner Unwilling to Use Another Form of Contraception, e.g. IUD, Diaphragm with Spermicide, Oral Contraceptives, Injectable Progesterone, Subdermal Implants or Tubal Ligation
Item
An unwillingness of the male subject to use a condom/spermicide in addition to having their female partner use another form of contraception such as an IUD, diaphragm with spermicide, oral contraceptives, injectable progesterone, subdermal implants or a tubal ligation if the woman could become pregnant from the time of the first dose of study medication until 30 days following administration of the last dose of study medication.
boolean
C1706180 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
C3873750 (UMLS CUI [1,3])
C1524063 (UMLS CUI [1,4])
C1705497 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0600109 (UMLS CUI [2,3])
C0021900 (UMLS CUI [3])
C0042241 (UMLS CUI [4])
C0009905 (UMLS CUI [5])
C0544374 (UMLS CUI [6])
C0375850 (UMLS CUI [7])
C0520483 (UMLS CUI [8])
History of Recent Drug or Alcohol Abuse
Item
History or evidence of drug or alcohol abuse within six months of study start.
boolean
C0262926 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C0085762 (UMLS CUI [1,3])
C0262926 (UMLS CUI [2,1])
C0332185 (UMLS CUI [2,2])
C0038586 (UMLS CUI [2,3])
Weekly Alcohol Intake
Item
Weekly alcohol intake of more than 21 units or an average daily intake of greater than three units.
boolean
C0001948 (UMLS CUI [1,1])
C0332174 (UMLS CUI [1,2])
Drug and Alcohol Urine Test
Item
Positive pre-study drugs of abuse or alcohol urine test
boolean
C0202274 (UMLS CUI [1,1])
C0868676 (UMLS CUI [1,2])
C0202304 (UMLS CUI [2,1])
C0042036 (UMLS CUI [2,2])
Recent Medication of Prescribed or Non-Prescribed Medication Excluding Paracetamol
Item
Has received prescribed or non-prescribed medication (including vitamins, herbal remedies and antacids) within 7 days prior to the dosing day, which in the opinion of the Principal/Co-Investigator, may interfere with the study procedures or compromise safety. Paracetamol for mild analgesia will be permitted
boolean
C0332185 (UMLS CUI [1,1])
C3166216 (UMLS CUI [1,2])
C0332185 (UMLS CUI [2,1])
C4081824 (UMLS CUI [2,2])
C0042890 (UMLS CUI [3])
C1360419 (UMLS CUI [4])
C0003138 (UMLS CUI [5])
C0000970 (UMLS CUI [6,1])
C2828389 (UMLS CUI [6,2])
Trial Participation with Investigational Drug
Item
Participation in a trial with and investigational drug within 30 days or 5 half lives (whichever is longer) prior to dosing
boolean
C2348568 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
Recent Blood Donation
Item
Donation of blood in excess of 500 mL within 3 months prior to the first dose of study medication
boolean
C0005794 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
History of Hypersensitivity to Lamotrigine
Item
History of hypersensitivity to lamotrigine
boolean
C0262926 (UMLS CUI [1,1])
C0020517 (UMLS CUI [1,2])
C0064636 (UMLS CUI [1,3])
History of Skin Rashes and Allergies
Item
History of clinically relevant skin rashes and allergies that, in the opinion of the investigator, might interfere with the conduct of the study.
boolean
C0262926 (UMLS CUI [1,1])
C0015230 (UMLS CUI [1,2])
C0262926 (UMLS CUI [2,1])
C0020517 (UMLS CUI [2,2])
Side Effect Affecting Professional Occupation, Operating Machinery, Driving
Item
Any subject where the potential CNS side effects of GW273225 and lamotrigine could affect their professional occupation, e.g. operating machinery, driving.
boolean
C0879626 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C2698884 (UMLS CUI [1,3])
C2698884 (UMLS CUI [2])
C0004379 (UMLS CUI [3])
History of Seizure Disorder or Brain Injury, any Condition with Predisposition to Seizure, Treatment with Medications lowering Seizure Threshold or Undergoing Abrupt Discontinuation of Alcohol or Sedatives
Item
Subject has current or past history of seizure disorder or brain injury (traumatic or disease-related), or any condition which, in the opinion of the investigator, predisposes to seizure; subject treated with other medications or treatment regimens that lower seizure threshold; subject undergoing abrupt discontinuation of alcohol or sedatives (including benzodiazepines).
boolean
C0262926 (UMLS CUI [1,1])
C0036572 (UMLS CUI [1,2])
C0262926 (UMLS CUI [2,1])
C0876926 (UMLS CUI [2,2])
C0220898 (UMLS CUI [3,1])
C0036572 (UMLS CUI [3,2])
C0234976 (UMLS CUI [4,1])
C0013227 (UMLS CUI [4,2])
C0457454 (UMLS CUI [5,1])
C0001948 (UMLS CUI [5,2])
C0457454 (UMLS CUI [6,1])
C0036557 (UMLS CUI [6,2])
Migraine Headaches Uncontrolled
Item
Poorly-controlled migraine headaches
boolean
C0149931 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Implanted metal Devices, Pacemakers
Item
Implanted metal devices including pacemakers
boolean
C0025080 (UMLS CUI [1,1])
C0021102 (UMLS CUI [1,2])
C0030163 (UMLS CUI [2])
Previous Brain Surgery
Item
Previous brain neurosurgery
boolean
C0524850 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
History of Neurological Disorders and Stroke
Item
History of neurological disorders and stroke
boolean
C0262926 (UMLS CUI [1,1])
C0027765 (UMLS CUI [1,2])
C0262926 (UMLS CUI [2,1])
C0038454 (UMLS CUI [2,2])
Item Group
Eligibility Review Following Screening
C0013893 (UMLS CUI-1)
Satisfaction of Inclusion/Exclusion Criteria
Item
Does the subject satisfy the Inclusion/Exclusion criteria of this study protocol?
boolean
C0242428 (UMLS CUI [1,1])
C1512693 (UMLS CUI [1,2])
C0242428 (UMLS CUI [2,1])
C0680251 (UMLS CUI [2,2])
Satisfaction of Inclusion/Exclusion Criteria Comment
Item
Does the subject satisfy the Inclusion/Exclusion criteria of this study protocol?
text
C0242428 (UMLS CUI [1,1])
C1512693 (UMLS CUI [1,2])
C0242428 (UMLS CUI [2,1])
C0680251 (UMLS CUI [2,2])
C0947611 (UMLS CUI [3])
Physician's Initials
Item
Physician's Initials
text
C1997894 (UMLS CUI [1,1])
C2986440 (UMLS CUI [1,2])
Date
Item
Date
date
C0011008 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial